News Medical

Administering immunotherapy drug before surgery for oral cavity cancer did not increase complications

A University of Cincinnati study found administering an immunotherapy drug before surgery for oral cavity cancer did not lead to increased rates of complications during and after surgery. The findings ...
ascopubs.org

Benefits of the Involvement of Dentists in Managing Oral Complications Among Patients With Oral Cavity and Oropharyngeal Cancer: An Analysis of Claims Data

Patients with oral cancer and oropharyngeal cancer frequently develop treatment-related oral complications that negatively affect patients' quality-of-life, cost, and health outcomes. We investigated ...
Healio

Neoadjuvant pembrolizumab does not increase surgical complications in oral cavity cancer

Please provide your email address to receive an email when new articles are posted on . DALLAS — Neoadjuvant pembrolizumab did not increase risk for serious surgical complications among patients with ...
ascopubs.org

Oral complications in patients with breast cancer treated with HER2-targeted therapies: A population-based cohort study across the United States.

The National Comprehensive Cancer Network (NCCN) Distress Thermometer and Problem List as a screening tool for sexual problems in adults with cancer. This is an ASCO Meeting Abstract from the 2023 ...
WebMD

What Are the Different Types of Oral Cancer Surgery?

What Are the Different Types of Oral Cancer Surgery? Oral cancer surgery refers to a group of procedures with different jobs: removing cancer, rebuilding areas affected by treatment, or restoring key ...
Science Daily

Immunotherapy drug did not increase surgery complications, study finds

Researchers recently published study results showing that administering immunotherapy drug pembrolizumab before surgery for oral cavity cancer did not increase rates of complication during and after ...